Alar Pharmaceuticals Inc. (6785.TWO)

TWD 138.5

(-1.07%)

Total Liabilities Summary of Alar Pharmaceuticals Inc.

  • Alar Pharmaceuticals Inc.'s latest annual total liabilities in 2023 was 76.08 Million TWD , up 839.02% from previous year.
  • Alar Pharmaceuticals Inc.'s latest quarterly total liabilities in 2024 Q2 was 69.15 Million TWD , down -12.78% from previous quarter.
  • Alar Pharmaceuticals Inc. reported annual total liabilities of 8.1 Million TWD in 2022, up 46.4% from previous year.
  • Alar Pharmaceuticals Inc. reported annual total liabilities of 5.53 Million TWD in 2021, up 3.03% from previous year.
  • Alar Pharmaceuticals Inc. reported quarterly total liabilities of 69.15 Million TWD for 2024 Q2, down -12.78% from previous quarter.
  • Alar Pharmaceuticals Inc. reported quarterly total liabilities of 179.93 Million TWD for 2023 Q3, down -0.09% from previous quarter.

Annual Total Liabilities Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Total Liabilities of Alar Pharmaceuticals Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 76.08 Million TWD 839.02%
2022 8.1 Million TWD 46.4%
2021 5.53 Million TWD 3.03%
2020 5.37 Million TWD 3604.83%
2019 145 Thousand TWD 0.0%

Peer Total Liabilities Comparison of Alar Pharmaceuticals Inc.

Name Total Liabilities Total Liabilities Difference
Allied Biotech Corporation 910.11 Million TWD 91.64%
GeneFerm Biotechnology Co., Ltd. 282.53 Million TWD 73.069%
Easywell Biomedicals, Inc. 589.98 Million TWD 87.103%
TTY Biopharm Company Limited 3.36 Billion TWD 97.741%
Synmosa Biopharma Corporation 3.62 Billion TWD 97.903%
Orient EuroPharma Co., Ltd. 6.64 Billion TWD 98.856%
Center Laboratories, Inc. 6.78 Billion TWD 98.879%
Tien Liang BioTech Co., Ltd. 161.05 Million TWD 52.755%
Orient Pharma Co., Ltd. 892.18 Million TWD 91.472%
InnoPharmax Inc. 48.64 Million TWD -56.404%
Johnson Chemical Pharmaceutical Works Co., Ltd. 320.99 Million TWD 76.296%
Excelsior Biopharma Inc. 472.87 Million TWD 83.909%
DV Biomed Co., Ltd. 765.87 Million TWD 90.065%
Foresee Pharmaceuticals Co., Ltd. 616.93 Million TWD 87.667%
Handa Pharmaceuticals, Inc. 280.88 Million TWD 72.911%
UniPharma Co., Ltd. 37.4 Million TWD -103.441%
Anxo Pharmaceutical Co., Ltd. 1.01 Billion TWD 92.506%
Winston Medical Supply Co., Ltd. 373.87 Million TWD 79.649%
Mercury Biopharmaceutical Corporation 49.72 Million TWD -53.032%
Bioray Biotech Co., Ltd 108.75 Million TWD 30.034%
TSH Biopharm Corporation Limited 133.62 Million TWD 43.058%